Correction: Identification of novel COX-2 / CYP19A1 axis involved in the mesothelioma pathogenesis opens new therapeutic opportunities.

Nuvoli, Barbara; Antoniani, Barbara; Libener, Roberta; Maconi, Antonio; Sacconi, Andrea; Carosi, Mariantonia; Galati, Rossella

Nuvoli, Barbara; Antoniani, Barbara; Libener, Roberta; Maconi, Antonio; Sacconi, Andrea; Carosi, Mariantonia; Galati, Rossella.

Afiliação

Nuvoli B; Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Antoniani B; Anatomy Pathology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Libener R; Department of Integrated Activities Research and Innovation, SS Antonio and Biagio General Hospital, Alessandria, Italy.
Maconi A; Department of Integrated Activities Research and Innovation, SS Antonio and Biagio General Hospital, Alessandria, Italy.
Sacconi A; Clinical Trial Center, Biostatistics and Bioinformatics Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Carosi M; Anatomy Pathology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Galati R; Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy. rossella.galati@ifo.gov.it.

J Exp Clin Cancer Res ; 42(1): 15, 2023 Jan 11.

Article em En | MEDLINE | ID: mdl-36627637

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Etiology_studies Idioma: En Revista: J Exp Clin Cancer Res Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google